A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
A gene, ATM , that is mutated in the autosomal recessive disorder ataxia telangiectasia (AT) was identified by positional cloning on chromosome 11q22-23. AT is characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, cancer predisposition, radiation sensitivity, and cell cycle abnormalities. The disease is genetically heterogeneous, with four complementation groups that have been suspected to represent different genes. ATM , which has a transcript of 12 kilobases, was found to be mutated in AT patients from all complementation groups, indicating that it is probably the sole gene responsible for this disorder. A partial ATM complementary DNA clone of 5.9 kilobases encoded a putative protein that is similar to several yeast and mammalian phosphatidylinositol-3′ kinases that are involved in mitogenic signal transduction, meiotic recombination, and cell cycle control. The discovery of ATM should enhance understanding of AT and related syndromes and may allow the identification of AT heterozygotes, who are at increased risk of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ATM is a defective gene in Ataxia-telangiectasia (A-T), an autosomal recessive disorder with early onset progressive cerebellar ataxia, oculocutaneous telangiectasia, and lymphoid tumor susceptibility [48, 49].”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [49]
Citations
Cites
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
A workbench for multiple alignment construction and analysis
Schuler, G. D., Altschul, S. F., & Lipman, D. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340090304 · Cited by 985
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789
Phosphatidylinositol 3-Kinase Encoded by Yeast VPS 34 Gene Essential for Protein Sorting
Schu, P. V., Takegawa, K., Fry, M. J., Stack, J. H., Waterfield, M. D., & Emr, S. D. (1993) · Science · doi:10.1126/science.8385367 · Cited by 778
Research works printed but not linked: 12
- Green, M. H. L., Journal of Cell Science 6: 127 (1987).
- Lange, E., American Journal of Human Genetics 57: 112 (1995).
- Lavin, M. F., Ataxia-Telangiectasia: 235 (1993).
- MCCONVILLE, C.M., GENETIC AND PHYSICAL MAPPING OF THE ATAXIA-TELANGIECTASIA LOCUS ON CHROMOSOME 11Q22-Q23, INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 66: S45 (1994).
- Meyn, M. S., American Journal of Human Genetics 55 Suppl.: A3 (1994).
- OSKATO, R, AMERICAN JOURNAL OF HUMAN GENETICS 53: A1055 (1993).
- Sedgwick, R. P., Handbook of Clinical Neurology 16: 347 (1991).
- Shiloh, Y., American Journal of Human Genetics 55 Suppl.: A49 (1994).
- Shiloh, Y., Ataxia-Telangiectasia: Genetics Neuropathology and Immunology of a Degenerative Disease of Childhood: 111 (1985).
- Shiloh Y. European Journal of Human Genetics in press.
- Uhrhammer, N., American Journal of Human Genetics 57: 103 (1995).
- ZAMPETTIBOSSELE.F, INT J RADIAT BIOL 39: 547 (1981).
Cited by
Items 201–300 of 1,009
Yan, S., Sorrell, M., & Berman, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1666-4 · Cited by 247
“tibility [48, 49].”
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei, M. H., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B. L., & Khanna, K. K. (2000) · PubMed · Cited by 295
Self-citationLoss of the ataxia–telangiectasia gene product causes oxidative damage in target organs
Barlow, C., Dennery, P. A., Shigenaga, M. K., Smith, M. A., Morrow, J. D., Roberts, L. J., Wynshaw-Boris, A., & Levine, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9915 · Cited by 246
Paciotti, V., Clerici, M., Lucchini, G., & Longhese, M. P. (2000) · Genes & Development · doi:10.1101/gad.14.16.2046 · Cited by 246
Genes involved in human premature ovarian failure
Persani, L., Rossetti, R., & Cacciatore, C. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0070 · Cited by 244
“1996) and are the underlying causes of ataxia teleangiectasia (AT; MIM #208900), an autosomal recessive neurodegenerative disorder characterized by uncoordinated movements and ocular telangiectases (Savitsky et al. 1995), chromosome instability, radiosensitivity, immunodeficiency, and a predisposition for cancer.”
BackgroundFlanigan, K. M., Gardner, K. L., Alderson, K., Galster, B., Otterud, B., Leppert, M., Kaplan, C. D., & Ptáček, L. J. (1996) · PubMed · Cited by 238
Patterned Purkinje cell death in the cerebellum
Sarna, J. R., & Hawkes, R. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00114-x · Cited by 241
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., & van't Veer, L. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302746 · Cited by 240
“Individuals with the autosomal recessive disorder ataxiatelangiectasia (A-T) (MIM 208900) are homozygous or compound heterozygous for a mutation in the ATM gene (Savitsky et al. 1995; Lavin and Shiloh 1997).”
BackgroundPremature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum
Tucker, E. J., Grover, S. R., Bachelot, A., Touraine, P., & Sinclair, A. H. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1047 · Cited by 239
“ATM mutations cause ataxia telangiectasia, which includes cerebellar degeneration, oculomotor dysfunction, immunodeficiency, cancer susceptibility, increased radiation sen- Figure 3.”
BackgroundInfluentialMre11 Protein Complex Prevents Double-Strand Break Accumulation during Chromosomal DNA Replication
Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D., & Gautier, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00294-5 · Cited by 239
The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling
Chou, M. M., & Blenis, J. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80064-6 · Cited by 239
Circular chromosome formation in a fission yeast mutant defective in two ATM homologues
Naito, T., Matsuura, A., & Ishikawa, F. (1998) · Nature Genetics · doi:10.1038/2517 · Cited by 237
Spring, K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C., Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., et al. (2002) · Nature Genetics · doi:10.1038/ng958 · Cited by 237
“The 7636del9 mutation was identified in 12 of 294 families analyzed (maternal and paternal groups counted separately”
BackgroundSelf-citationCancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries
Olsen, J. H., Hahnemann, J. M., Borresen-Dale, A.-L., Brondum-Nielsen, K., Hammarstrom, L., Kleinerman, R., Kaariainen, H., Lonnqvist, T., Sankila, R., Seersholm, N., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.121 · Cited by 237
Kamsler, A., Daily, D., Hochman, A., Stern, N., Shiloh, Y., Rotman, G., & Barzilai, A. (2001) · PubMed · Cited by 235
Self-citationATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome
Schneider, J. G., Finck, B. N., Ren, J., Standley, K. N., Takagi, M., Maclean, K. H., Bernal-Mizrachi, C., Muslin, A. J., Kastan, M. B., & Semenkovich, C. F. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.002 · Cited by 235
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
de Jong, M. M., Nolte, I. M., te Meerman, G. J., van der Graaf, W. T. A., Oosterwijk, J. C., Kleibeuker, J. H., Schaapveld, M., & de Vries, E. G. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.225 · Cited by 235
Primary Immunodeficiency Diseases Due to Defects in Lymphocytes
Buckley, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431806 · Cited by 244
van Vugt, M. A. T. M., Gardino, A. K., Linding, R., Ostheimer, G. J., Reinhardt, H. C., Ong, S.-E., Tan, C. S., Miao, H., Keezer, S. M., Li, J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000287 · Cited by 232
“Their importance, however, is highlighted by the observation that interference with ATM and Chk2 function severely impairs the checkpoint response to IR and other DSB-inducing lesions, and mutation of the genes encoding for ATM and Chk2 results in the cancer-prone AtaxiaTelangiectasia syndrome, and familial breast and…”
Vanier, M. T., Duthel, S., Rodriguez‐Lafrasse, C., Pentchev, P. G., & Carstea, E. D. (1996) · PubMed Central · Cited by 233
Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control
Boisvert, F.-M., Déry, U., Masson, J.-Y., & Richard, S. (2005) · Genes & Development · doi:10.1101/gad.1279805 · Cited by 231
Garzon, M. C., Huang, J. T., Enjolras, O., & Frieden, I. J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.066 · Cited by 234
ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich, F., Rasio, D., Kitada, S., Starostik, P., Kipps, T. J., Keating, M., Albitar, M. X., Reed, J. C., & Croce, C. M. (1999) · PubMed · Cited by 232
Genomic Instability and Cancer
Wei Dai, Y. Y. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000165 · Cited by 225
Chromosome instability syndromes
Taylor, A. M. R., Rothblum-Oviatt, C., Ellis, N. A., Hickson, I. D., Meyer, S., Crawford, T. O., Smogorzewska, A., Pietrucha, B., Weemaes, C., & Stewart, G. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0113-0 · Cited by 222
Self-citationScott, S. P., Bendix, R., Chen, P., Clark, R., Dörk, T., & Lavin, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012329699 · Cited by 228
Self-citationThe Mre11 complex and ATM: collaborating to navigate S phase
Petrini, J. H. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00091-0 · Cited by 228
Wright, J. A., Keegan, K. S., Herendeen, D. R., Bentley, N. J., Carr, A. M., Hoekstra, M. F., & Concannon, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7445 · Cited by 226
Characterization of ATM gene mutations in 66 ataxia telangiectasia families
Sandoval, N. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.69 · Cited by 226
“The gene mutated in AT, ATM, has been localized to chromosome 11q23 (14) and subseque ntly was isolated and characterized (15,16).”
BackgroundWestphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., & Leder, P. (1997) · Nature Genetics · doi:10.1038/ng0897-397 · Cited by 226
Neurogenesis in aging and age-related neurodegenerative diseases
Culig, L., Chu, X., & Bohr, V. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101636 · Cited by 218
Prediction of Radiation Sensitivity Using a Gene Expression Classifier
Torres-Roca, J. F., Eschrich, S., Zhao, H., Bloom, G., Sung, J., McCarthy, S., Cantor, A. B., Scuto, A., Li, C., Zhang, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0656 · Cited by 219
Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways
Rhind, N., & Russell, P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.22.3889 · Cited by 219
Series Introduction: JAK-STAT signaling in human disease
Schindler, C. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15644 · Cited by 218
ATM Is Required for Efficient Recombination between Immunoglobulin Switch Regions
Reina-San-Martin, B., Chen, H. T., Nussenzweig, A., & Nussenzweig, M. C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041162 · Cited by 219
Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification
Morita, K., Miyamoto, T., Fujita, N., Kubota, Y., Ito, K., Takubo, K., Miyamoto, K., Ninomiya, K., Suzuki, T., Iwasaki, R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062525 · Cited by 218
“Ataxia telangiectasia mutated (ATM) functions in oxidative defense, and mice with Atm loss of function show premature aging caused by defects in DNA repair (12, 13).”
BackgroundATM and breast cancer susceptibility
Ahmed, M., & Rahman, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209873 · Cited by 216
“3 and consists of 66 exons, 62 of which encode a protein of 3056 amino acids (Savitsky et al., 1995).”
BackgroundMethodWang, L., Heidt, D. G., Lee, C. J., Yang, H., Logsdon, C. D., Zhang, L., Fearon, E. R., Ljungman, M., & Simeone, D. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.018 · Cited by 214
“No germline ATDC mutations were found in AT patients, and subsequently the gene responsible for AT was identified as ataxia-telangiectasia mutated (ATM) (Savitsky et al., 1995).”
BackgroundHuman genetic diseases: a cross-talk between man and yeast
Foury, F. (1997) · Gene · doi:10.1016/s0378-1119(97)00140-6 · Cited by 215
ATM, ATR and DNA-PKcs kinases—the lessons from the mouse models: inhibition ≠ deletion
Menolfi, D., & Zha, S. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-0376-x · Cited by 207
Mre11 Complex and DNA Replication: Linkage to E2F and Sites of DNA Synthesis
Maser, R. S., Mirzoeva, O. K., Wells, J., Olivares, H., Williams, B. R., Zinkel, R. A., Farnham, P. J., & Petrini, J. H. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6006-6016.2001 · Cited by 212
“Mutations in the ATM, MRE11, or NBS1 gene (from patients with ataxia-telangiectasia [A-T], ataxia-telangiectasia-like disorder [A-TLD], or Nijmegen breakage syndrome [NBS], respectively) abrogate this checkpoint (12, 52, 58, 66).”
BackgroundNuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia
Li, J., Chen, J., Ricupero, C. L., Hart, R. P., Schwartz, M. S., Kusnecov, A., & Herrup, K. (2012) · Nature Medicine · doi:10.1038/nm.2709 · Cited by 210
Le Ber, I. (2004) · Brain · doi:10.1093/brain/awh080 · Cited by 210
Angèle, S., Romestaing, P., Moullan, N., Vuillaume, M., Chapot, B., Friesen, M. D., Jongmans, W., Cox, D. G., Pisani, P., Gérard, J. P., et al. (2003) · PubMed · Cited by 208
ATM signaling and genomic stability in response to DNA damage
Lavin, M. F., Birrell, G., Chen, P., Kozlov, S., Scott, S., & Gueven, N. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.04.020 · Cited by 209
Self-citationCremona, C. A., & Behrens, A. (2014) · Oncogene · doi:10.1038/onc.2013.275 · Cited by 204
The mismatch repair system is required for S-phase checkpoint activation
Brown, K. D., Rathi, A., Kamath, R., Beardsley, D. I., Zhan, Q., Mannino, J. L., & Baskaran, R. (2003) · Nature Genetics · doi:10.1038/ng1052 · Cited by 206
Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., Ohyashiki, J. H., & Ohyashiki, K. (2003) · Oncogene · doi:10.1038/sj.onc.1206833 · Cited by 206
“ATM is a protein kinase that shares similarities with the phosphatidylinositol 3-kinase involved in signaling pathways that regulate genome stability and cell cycle check point arrest after DNA damage or incomplete DNA replication (Savitsky et al., 1995; Lavin and Shiloh, 1997).”
BackgroundFORAY, A. P. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143266 · Cited by 205
Griffiths, D. J., Barbet, N. C., McCready, S., Lehmann, A. R., & Carr, A. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00269.x · Cited by 205
Functional interaction between FOXO3a and ATM regulates DNA damage response
Tsai, W.-B., Chung, Y. M., Takahashi, Y., Xu, Z., & Hu, M. C.-T. (2008) · Nature Cell Biology · doi:10.1038/ncb1709 · Cited by 203
Clements, P. M., Breslin, C., Deeks, E. D., Byrd, P. J., Ju, L., Bieganowski, P., Brenner, C., Moreira, M.-C., Taylor, A. M. R., & Caldecott, K. W. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.06.017 · Cited by 203
Self-citationChk2 Activation Dependence on Nbs1 after DNA Damage
Buscemi, G., Savio, C., Zannini, L., Miccichè, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5214-5222.2001 · Cited by 201
“that ATM (AT mutated) (39) and Nbs1 (38, 51), the gene”
BackgroundSelf-citationDrosophila Checkpoint Kinase 2 Couples Centrosome Function and Spindle Assembly to Genomic Integrity
Takada, S., Kelkar, A., & Theurkauf, W. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00202-2 · Cited by 201
Insulin Resistance and Atherosclerosis
Razani, B., Chakravarthy, M. V., & Semenkovich, C. F. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.05.001 · Cited by 199
Synthetic lethality: exploiting the addiction of cancer to DNA repair
Shaheen, M., Allen, C., Nickoloff, J. A., & Hromas, R. (2011) · Blood · doi:10.1182/blood-2011-01-313734 · Cited by 198
Autophosphorylation and ATM Activation
Kozlov, S. V., Graham, M. E., Jakob, B., Tobias, F., Kijas, A. W., Tanuji, M., Chen, P., Robinson, P. J., Taucher-Scholz, G., Suzuki, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204065 · Cited by 197
Self-citationPredictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms
Listgarten, J., Damaraju, S., Poulin, B., Cook, L., Dufour, J., Driga, A., Mackey, J., Wishart, D., Greiner, R., & Zanke, B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1115-03 · Cited by 200
“Inherited cancer predisposition from the inheritance of single genes almost exclusively results from abnormalities in DNA maintenance genes such as DNA double-strand break repair factors BRCA1 or BRCA2, which are abnormal in familial breast cancer (2); the check point kinase ATM, which is mutated in ataxia telangiecta…”
BackgroundCancer Risk and the ATM Gene: a Continuing Debate
Khanna, K. K. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.795 · Cited by 200
Słabicki, M., Theis, M., Krastev, D. B., Samsonov, S., Mundwiller, E., Junqueira, M., Paszkowski-Rogacz, M., Teyra, J., Heninger, A.-K., Poser, I., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000408 · Cited by 197
“Based on our findings, we propose that HSP might also be a result of impaired DNA repair, adding HSP to the growing list of neurodegenerative diseases caused by DNA repair deficiencies [4,5,7,8].”
BackgroundAutosomal recessive cerebellar ataxias
Palau, F., & Espinós, C. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-47 · Cited by 198
“A transcript of 12 kb encodes a protein of 3056 amino acids with 370 kDa, which is a member of the phosphoinositol-3 kinase (PI-3K)-like serine/threonine kinases involved in the cell cycle checkpoint control and DNA repair [51,52].”
Volkmer, E., & Karnitz, L. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.567 · Cited by 197
A Rad3–Rad26 complex responds to DNA damage independently of other checkpoint proteins
Edwards, R. J., Bentley, N. J., & Carr, A. M. (1999) · Nature Cell Biology · doi:10.1038/15623 · Cited by 197
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
Ambrose, M., & Gatti, R. A. (2013) · Blood · doi:10.1182/blood-2012-09-456897 · Cited by 196
Self-citationStark, G. R., & Taylor, W. R. (2004) · Checkpoint Controls and Cancer · doi:10.1385/1-59259-788-2:051 · Cited by 195
“Atm was originally identified as the gene mutated in the recessive autosomal disease ataxia telangiectasia (80).”
BackgroundMutations associated with variant phenotypes in ataxia-telangiectasia.
McConville, C. M., Stanković, T., Byrd, P. J., McGuire, G. M., Yao, Q. Y., Lennox, G. G., & Taylor, A. M. R. (1996) · PubMed Central · Cited by 220
Self-citationMouse models of human disease. Part II: recent progress and future directions.
Bedell, M. A., Largaespada, D. A., Jenkins, N. A., & Copeland, N. G. (1997) · Genes & Development · doi:10.1101/gad.11.1.11 · Cited by 195
“142623 Schuchardt et al. (1994); *van Heyningen ( 1994); *Chakravarti 11996) 203100 *Jackson (1994); *Spritz (1994b); *Barsch 11996)”
Regulatory ubiquitylation in response to DNA double-strand breaks
Panier, S., & Durocher, D. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.01.013 · Cited by 193
Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
Tavtigian, S. V., Oefner, P. J., Babikyan, D., Hartmann, A., Healey, S., Le Calvez-Kelm, F., Lesueur, F., Byrnes, G. B., Chuang, S.-C., Forey, N., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.08.018 · Cited by 194
Molecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy
D'Andrea, A. D., & Grompe, M. (1997) · Blood · doi:10.1182/blood.v90.5.1725 · Cited by 194
Hekmat-Nejad, M., You, Z., Yee, M.-C., Newport, J. W., & Cimprich, K. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00855-1 · Cited by 192
STRUCTURE, FUNCTION, AND REPLICATION OF SACCHAROMYCES CEREVISIAE TELOMERES
Zakian, V. A. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.141 · Cited by 193
“TheATMgene is mutated in individuals suffering from ataxia telangiectasia (AT), a disease characterized by a wide spectrum of defects including a∼ 100-fold increase in cancer susceptibility (reviewed in Ref.”
BackgroundInfluentialTargeting ATR in DNA damage response and cancer therapeutics
Fokas, E., Prevo, R., Hammond, E. M., Brunner, T. B., McKenna, W. G., & Muschel, R. J. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.002 · Cited by 189
Hruban, R. H., Petersen, G. M., Ha, P. K., & Kern, S. E. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30282-5 · Cited by 191
van Os, N. J. H., Roeleveld, N., Weemaes, C. M. R., Jongmans, M. C. J., Janssens, G. O., Taylor, A. M. R., Hoogerbrugge, N., & Willemsen, M. A. A. P. (2016) · Clinical Genetics · doi:10.1111/cge.12710 · Cited by 191
“This gene codes for the ATM protein, which is involved in cell cycle control and DNA repair (1).”
BackgroundSelf-citationGenetic and environmental factors in cancer and neurodegenerative diseases
Migliore, L., & Coppedè, F. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00046-7 · Cited by 191
Gately, D. P., Hittle, J. C., Chan, G. K. T., & Yen, T. J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.9.2361 · Cited by 190
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
Bristow, R. G., Benchimol, S., & Hill, R. P. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01806-3 · Cited by 192
Localization of a Portion of Extranuclear ATM to Peroxisomes
Watters, D., Kedar, P., Spring, K., Bjorkman, J., Chen, P., Gatei, M., Birrell, G., Garrone, B., Srinivasa, P., Crane, D. I., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34277 · Cited by 190
Self-citationDNA Damage Responses: Mechanisms and Roles in Human Disease
Kastan, M. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0020 · Cited by 189
“A major breakthrough occurred when Yossi Shiloh and his colleagues cloned the gene mutated in ataxia-telangiectasia, ATM (7).”
Utilization of Oriented Peptide Libraries to Identify Substrate Motifs Selected by ATM
O'Neill, T., Dwyer, A. J., Ziv, Y., Chan, D. W., Lees-Miller, S. P., Abraham, R. H., Lai, J. H., Hill, D., Shiloh, Y., Cantley, L. C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001002200 · Cited by 189
Self-citationMice with a targeted disruption of the Fanconi anemia homolog Fanca
Cheng, N. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.12.1805 · Cited by 163
ATM Is Required for IκB Kinase (IKK) Activation in Response to DNA Double Strand Breaks
Li, N., Banin, S., Ouyang, H., Li, G. C., Courtois, G., Shiloh, Y., Karin, M., & Rotman, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009809200 · Cited by 188
Self-citationRecent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
Bolderson, E., Richard, D. J., Zhou, B.-B. S., & Khanna, K. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0096 · Cited by 187
Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK Activation
Fu, X., Wan, S., Lyu, Y. L., Liu, L. F., & Qi, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002009 · Cited by 187
“The major player in response to DSBs is ATM (ataxia telangiectasia mutated), which belongs to the PIKK (phosphoinositide 3-kinase related kinase) family of protein kinases [23,24].”
BackgroundDNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 186
SNP discovery in associating genetic variation with human disease phenotypes
Suh, Y., & Vijg, J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.01.005 · Cited by 186
Murray, J. M., Lindsay, H. D., Munday, C. A., & Carr, A. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.6868 · Cited by 184
“Since there is good evidence that most of the damage response pathways are highly structurally and functionally conserved (5, 13, 28, 33, 51, 53), we are studying these pathways in the fission yeast model system.”
BackgroundPayne, S. R., & Kemp, C. J. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi223 · Cited by 186
Anheim, M., Fleury, M., Monga, B., Laugel, V., Chaigne, D., Rodier, G., Ginglinger, E., Boulay, C., Courtois, S., Drouot, N., et al. (2010) · neurogenetics · doi:10.1007/s10048-009-0196-y · Cited by 185
“Genetic analysis included (Table 1): FRDA [4], AVED [16, 18], AOA1 [10, 36], AOA2 [8], AT [ 5 ], Marinesco–Sjogren syndrome (MSS) [37], autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) [38], ATLD [11], recessive ataxia associated with coenzyme Q10 deficiency (ARCA2) [13], dominant spinocerebellar ata…”
MethodThe ATM homologue MEC1 is required for phosphorylation of replication protein A in yeast
Brush, G. S., Morrow, D. M., Hieter, P., & Kelly, T. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15075 · Cited by 185
Cohen, P. E., Pollack, S. E., & Pollard, J. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0017 · Cited by 184
“The majority of cases of A-T are caused by mutations in the ATM gene, which encodes a member of the phosphatidylinositol-3 kinase family of proteins that includes A-T and Rad3-related protein (ATR) and DNA-PKcs (298).”
BackgroundATM activation in the presence of oxidative stress
Guo, Z., Deshpande, R., & Paull, T. T. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14323 · Cited by 181
“A-T patients also have small clusters of enlarged ocular blood vessels (oculocutaneous telangiectasia), a weakened immune system and increased risk of developing cancer, particularly lymphomas and leukemias.2,3 ATM activation in the presence of oxidative stress Zhi Guo, Rajashree Deshpande and Tanya T. Paull* The Howa…”
BackgroundInfluentialATM binds to β-adaptin in cytoplasmic vesicles
Lim, D.-S., Kirsch, D. G., Canman, C. E., Ahn, J.-H., Ziv, Y., Newman, L. S., Darnell, R. B., Shiloh, Y., & Kastan, M. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10146 · Cited by 181
Self-citationRabès, J., Varret, M., Saint-Jore, B., Erlich, D., Jondeau, G., Krempf, M., Giraudet, P., Junien, C., & Boileau, C. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:2<164::aid-humu9>3.0.co;2-k · Cited by 39
Self-citationAtaxia-telangiectasia: diagnosis and treatment
Perlman, S., Becker-Catania, S., & Gatti, R. A. (2003) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(03)00026-3 · Cited by 181
Self-citationNuclear factor-κB/Rel proteins
Grilli, M., & Memo, M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00214-7 · Cited by 180
Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice
Borghesani, P. R., Alt, F. W., Bottaro, A., Davidson, L., Aksoy, S., Rathbun, G. A., Roberts, T. M., Swat, W., Segal, R. A., & Gu, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3336 · Cited by 178
Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
Pui, C.-H., Nichols, K. E., & Yang, J. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0136-6 · Cited by 177
PI 3-kinase: a pivotal pathway in T-cell activation?
Ward, S. G., June, C. H., & Olive, D. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80618-9 · Cited by 178
Metadata
- Authors
- Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., & Shiloh, Y.
- Affiliations
- Tel Aviv University (IL)
- Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
- National Institutes of Health (US)
- Sheba Medical Center (IL)
- Yale University (US)
- The University of Texas Southwestern Medical Center (US)
- University of California, Los Angeles (US)
- Sapienza University of Rome (IT)
- Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- QIMR Berghofer Medical Research Institute (AU)
- Erasmus University Rotterdam (NL)
- University of Birmingham (GB)
- University of Sussex (GB)
- ORCID
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1749-1753
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159168998
- Cited by
- 2,785
- References
- 54
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 45 · 2023: 34 · 2022: 43 · 2021: 73 · 2020: 60 · 2019: 61 · 2018: 53 · 2017: 67 · 2016: 59 · 2015: 69 · 2014: 80 · 2013: 75 · 2012: 87
- FWCI
- 70.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hg000882-02)
- National Human Genome Research Institute (HG00882)
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- ataxia telangiectasia, ATM gene, phosphatidylinositol 3-kinase, positional cloning, complementation groups, cerebellar degeneration, immunodeficiency, chromosomal instability, cancer susceptibility, radiosensitivity, cell cycle regulation, mitogenic signaling, meiotic recombination
- MeSH terms
- Amino Acid Sequence, Ataxia Telangiectasia, Cell Cycle, Chromosome Mapping, Chromosomes, Human, Pair 11, Cloning, Molecular, DNA-Binding Proteins, Female, Genetic Complementation Test, Heterozygote, Humans, Male, Meiosis, Molecular Sequence Data, Neoplasms, Nucleic Acid Hybridization, Proteins, Radiation Tolerance, Signal Transduction, Protein Serine-Threonine Kinases, Sequence Deletion, Phosphotransferases (Alcohol Group Acceptor), DNA, Complementary, Chromosomes, Artificial, Yeast, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.